Orals

 

17 Organization(s)

AcelRx Pharmaceuticals

Business Area(s): 
Description: 

Oral-Transmucosal Drug Delivery

Acucela

Business Area(s): 
Description: 

Orally-Available Ophthalmic Treatments

Arno Therapeutics

Business Area(s): 
Description: 

Oral Small Molecules

Atlantic Pharmaceuticals

Business Area(s): 
Description: 

Oral Abuse-Resistant Delivery

Avaxia Biologics

Business Area(s): 
Description: 

Orally Available Anti-TNF Antibody

Cherokee Pharmaceuticals

Business Area(s): 
Description: 

Oral Extended Release

Entrega (Enlight Biosciences)

Business Area(s): 
Description: 

Oral delivery of peptides, proteins, and poorly bioavailable small molecules

Fusion Pharmaceuticals

Business Area(s): 
Description: 

Oral suspensions of existing solid dosage medicines

MentiNova

Business Area(s): 
Description: 

Oral treatment for L-Dopa Induced Dyskinesia

Morphic Therapeutic

Business Area(s): 
Description: 

Working to develop the first orally administered integrin therapeutics for patients with immunological, fibrotic, neoplastic, and vascular diseases.

Oragenics

Business Area(s): 
Description: 

Oral Care Probiotics

Protagonist Therapeutics

Business Area(s): 
Description: 

Oral peptides for GI indications

Rani Therapeutics

Business Area(s): 
Description: 

Orally delivered Biologics

Targeted Cell Therapies

Business Area(s): 
Description: 

Oral Biologics

Vaxart

Business Area(s): 
Description: 

Oral Vaccines

X4 Pharmaceuticals

Business Area(s): 
Description: 

Oral small molecules

Zenith Epigenetics

Business Area(s): 
Description: 

Orally-active small molecules